TEL AVIV, Israel, March 18, 2019 /PRNewswire-PRWeb/ -- ART MEDICAL, a medical device company that specializes in nutrition-based
Recent studies suggest that nutritional guidelines across the majority of intensive care units are not being implemented. Current approaches to determining feeding goals don't measure a patient's energy expenditure and, as a result, 60 percent of patients receive inaccurate nutrition targets. Approximately 75 percent of ICU patients received less than 80 percent of target nutrition on the first days.1 These findings likely underestimate the challenge of maintaining proper nutrition in ICU patients, as most ICUs perform nutrition audits only one day each year.1
"One of the key obstacles to effectively implementing nutritional guidelines and preventing malnutrition is the lack of innovative technology to support critical care physicians," said Prof. Singer. "Most ICUs are not equipped with computerized information systems to continuously calculate a patient's energy balance, account for time lost by stopping feeding, and compensate for nutritional losses. The lack of accurate, real-time data about a patient's feeding status and nutritional needs may increase the risk of morbidity and mortality."
As described in the new publication, medical nutrition therapy can be improved with ICU feeding technology that:
"Major risks and in-hospital complications are inter-connected in ICU patients, none of which are addressed sufficiently with the current standard of care," said Liron. "There is need for a personalized nutrition-based ICU system that verifies the tube position and captures a patient's energy consumption in real-time, per the new guidelines, that correlates with changes in patient's status and continuously assesses patient's nutritional needs."
The next generation of ICU feeding technology will further explore artificial intelligence and prediction algorithms to provide options for adjusting nutritional plans accordingly.
About ART MEDICAL ART MEDICAL was founded by Liron Elia in 2009. The company offers a range of products that optimize enteral feeding as well as detect and prevent aspiration pneumonia, VAP and Acute Kidney Injury in critical care patients. The first-generation version of the product has received FDA clearance and CE approval. The company continues to expand its technology and work on clinical validations. The company is based in Israel and Palo Alto.
Contact Erich Sandoval (US) Lazar Partners +1 917-497-2867 esandoval(at)lazarpartners.com
Ashley Tapp/Rozi Morris (Europe) Instinctif Partners +44 (0)20 7457 2020 ashley.tapp(at)instinctif.com
1 Bendavid I, Singer P et al. NutritionDay ICU: A 7 year worldwide prevalence study of nutrition practice in intensive care. Clin Nutr. 2017; 36(4):1122 - 1129
SOURCE ART Medical
Subscribe to our Free Newsletters!